🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

148,76 USD

Máx. histórico

156,45

76 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-4,92%

Rango 52 semanas

85,80 – 156,92

Variación hoy

+1,38%

Cierre anterior

146,73

Rango de hoy

146,52 – 148,80

Volumen hoy

7.557.172

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,43%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
150,26 (puede no estar actualizado)
Dividend yield
2,32% (puede no estar actualizado)
Precio objetivo analistas
161,53 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 5 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,29%
Fecha de pago Importe por participación
14/12/2022 0,7300 USD
14/09/2022 0,6900 USD
14/06/2022 0,6900 USD
14/03/2022 0,6900 USD
14/12/2021 0,6900 USD
14/09/2021 0,6500 USD
14/06/2021 0,6500 USD
12/03/2021 0,6202 USD
14/12/2020 0,6202 USD
14/09/2020 0,5821 USD
12/06/2020 0,5821 USD
13/03/2020 0,5821 USD
13/12/2019 0,5821 USD
13/09/2019 0,5248 USD
14/06/2019 0,5248 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
11/03/2022 78,32 79,63 78,20 78,26 +0,48% 1,83% 9.424.500
10/03/2022 77,63 78,20 77,33 77,89 +0,13% 1,12% 8.972.200
09/03/2022 77,62 78,22 77,05 77,79 +1,09% 1,51% 9.746.000
08/03/2022 77,25 78,09 76,56 76,95 -1,00% 1,98% 10.184.100
07/03/2022 77,01 78,29 76,08 77,73 -0,13% 2,87% 14.008.400
04/03/2022 76,68 77,86 76,02 77,83 +0,88% 2,40% 12.216.300
03/03/2022 76,77 77,54 76,41 77,15 +0,63% 1,47% 8.191.100
02/03/2022 76,31 77,22 76,06 76,67 +0,43% 1,52% 9.697.500
01/03/2022 76,50 77,76 75,95 76,34 -0,31% 2,37% 9.807.300
28/02/2022 75,83 76,76 74,78 76,58 +0,34% 2,61% 14.126.100
25/02/2022 74,20 77,29 74,17 76,32 +3,82% 4,20% 13.665.900
24/02/2022 75,10 75,32 72,88 73,51 -3,07% 3,25% 21.135.600
23/02/2022 76,19 76,44 75,62 75,84 -0,14% 1,08% 9.659.100
22/02/2022 76,46 76,86 75,61 75,95 -0,55% 1,63% 9.052.500
18/02/2022 76,32 76,86 75,89 76,37 +0,01% 1,27% 8.780.500
17/02/2022 76,85 76,93 76,00 76,36 -1,11% 1,21% 8.889.300
16/02/2022 77,20 77,80 76,93 77,22 -0,76% 1,13% 9.981.300
15/02/2022 77,51 78,19 77,32 77,81 +1,75% 1,12% 11.425.600
14/02/2022 76,63 76,70 75,11 76,47 -0,22% 2,07% 9.881.100
11/02/2022 76,40 77,90 76,17 76,64 +0,10% 2,26% 9.342.300
10/02/2022 76,36 76,77 75,93 76,56 +0,04% 1,10% 12.437.600
09/02/2022 77,17 77,33 76,41 76,53 -0,49% 1,19% 15.183.100
08/02/2022 77,10 77,33 75,82 76,91 -0,86% 1,96% 17.486.500
07/02/2022 78,79 78,92 77,44 77,58 -1,25% 1,88% 23.615.300
04/02/2022 78,51 79,55 78,20 78,56 -0,57% 1,72% 10.716.200
03/02/2022 81,65 81,80 78,40 79,01 -3,66% 4,16% 19.181.400
02/02/2022 81,80 82,30 81,26 82,01 +0,11% 1,27% 13.988.200
01/02/2022 81,96 82,12 81,08 81,92 +0,54% 1,27% 10.803.300
31/01/2022 81,02 81,72 80,80 81,48 +0,72% 1,14% 13.035.000
28/01/2022 79,54 80,99 79,18 80,90 +0,40% 2,28% 13.915.300